# Huang Lian (Chinese Herb) in Treating Patients With Advanced Solid Tumors

> **NCT00014378** · PHASE1 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 34 (actual)

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** Chinese Herb Huanglian (Coptis chinesis)

## Key facts

- **NCT ID:** NCT00014378
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-10
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2015-12-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00014378

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00014378, "Huang Lian (Chinese Herb) in Treating Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00014378. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*